INTRODUCTION: Age and hypertension are two major determinants of arterial stiffness, as well as endothelial dysfunction. The present study was designed to test whether a chronic reduction of endogenous nitric oxide (NO) produces arterial stiffening close to that observed in old spontaneously hypertensive rats (SHR), and also to study the effect of an acute or a chronic decrease in blood pressure (BP) on aortic distensibility. METHODS: BP, aortic stiffness, endothelial dysfunction and remodelling were measured in male adult (20-week-old) SHR, in adult SHR treated with a nonspecific NO synthase inhibitor L-NAME (SHR/L-NAME) for 2 weeks, in adult SHR/L-NAME cotreated with perindopril (1 mg/kg/day) and in old SHR (55-week-old). Age-matched WKY were used as a normotensive group. RESULTS: Aortic endothelial dysfunction, remodelling and stiffening appeared in old SHR. Reduction of NO production in adult SHR caused similar alterations. Acute decreases in BP in SHR/L-NAME did not improve isobaric aortic distensibility but a chronic reduction of BP prevented endothelial dysfunction, aortic remodelling and aortic wall stiffening. CONCLUSION: NO reduction in adult SHR induces aortic alterations similar to those observed during aging, which supports the major role of NO in the development of arterial stiffening. These aortic alterations can be prevented by angiotensin-converting enzyme inhibitor treatment.
INTRODUCTION: Age and hypertension are two major determinants of arterial stiffness, as well as endothelial dysfunction. The present study was designed to test whether a chronic reduction of endogenous nitric oxide (NO) produces arterial stiffening close to that observed in old spontaneously hypertensiverats (SHR), and also to study the effect of an acute or a chronic decrease in blood pressure (BP) on aortic distensibility. METHODS: BP, aortic stiffness, endothelial dysfunction and remodelling were measured in male adult (20-week-old) SHR, in adult SHR treated with a nonspecific NO synthase inhibitor L-NAME (SHR/L-NAME) for 2 weeks, in adult SHR/L-NAME cotreated with perindopril (1 mg/kg/day) and in old SHR (55-week-old). Age-matched WKY were used as a normotensive group. RESULTS: Aortic endothelial dysfunction, remodelling and stiffening appeared in old SHR. Reduction of NO production in adult SHR caused similar alterations. Acute decreases in BP in SHR/L-NAME did not improve isobaric aortic distensibility but a chronic reduction of BP prevented endothelial dysfunction, aortic remodelling and aortic wall stiffening. CONCLUSION: NO reduction in adult SHR induces aortic alterations similar to those observed during aging, which supports the major role of NO in the development of arterial stiffening. These aortic alterations can be prevented by angiotensin-converting enzyme inhibitor treatment.
Authors: Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb Journal: Pharmacol Res Date: 2016-09-14 Impact factor: 7.658
Authors: Arthur J A Leloup; Cor E Van Hove; Ammar Kurdi; Sofie De Moudt; Wim Martinet; Guido R Y De Meyer; Dorien M Schrijvers; Gilles W De Keulenaer; Paul Fransen Journal: J Physiol Date: 2016-08-02 Impact factor: 5.182
Authors: Benard O Ogola; Margaret A Zimmerman; Gabrielle L Clark; Caleb M Abshire; Kaylee M Gentry; Kristin S Miller; Sarah H Lindsey Journal: Am J Physiol Heart Circ Physiol Date: 2018-07-20 Impact factor: 4.733
Authors: Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman Journal: Hypertension Date: 2019-06 Impact factor: 10.190
Authors: Nancy L Sehgel; Zhe Sun; Zhongkui Hong; William C Hunter; Michael A Hill; Dorothy E Vatner; Stephen F Vatner; Gerald A Meininger Journal: Hypertension Date: 2014-12-01 Impact factor: 10.190
Authors: Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Zachary I Grunewald; Francisco J Cabral-Amador; Tadashi Yoshida; David A Brenner; Camila Manrique-Acevedo; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla Journal: Am J Physiol Heart Circ Physiol Date: 2021-07-09 Impact factor: 5.125
Authors: Gwennan André; Juan E Sandoval; Kevin Retailleau; Laurent Loufrani; Gilles Toumaniantz; Stefan Offermanns; Malvyne Rolli-Derkinderen; Gervaise Loirand; Vincent Sauzeau Journal: J Am Heart Assoc Date: 2014-06-17 Impact factor: 5.501